LTR Pharma is a public company, with operations based in Brisbane, Australia. Our focus is on holistically improving men’s health, physically and mentally, through the commercialisation of an innovative intranasal spray treatment for Erectile Dysfunction (ED).
ED is a pressing health issue for millions of men that can negatively impact self-esteem and relationships, across multiple age brackets.
Our lead product SPONTAN® is set apart from existing ED therapies by its mechanism of action – intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less.
LTR Pharma is proudly aiming to restore greater control over the timing, spontaneity, and enjoyment of sexual experiences.